Sentences with phrase «human immunodeficiency virus type»

Extracts of this geranium plant inactivate human immunodeficiency virus type 1 (HIV - 1) and prevent the virus from invading human cells, new research shows.

The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV - 1).

The five viruses include human immunodeficiency virus type 1, human T - cell lymphotropic virus type 1, Epstein - Barr virus, Kaposi sarcoma - associated herpesvirus, and Merkel cell polyomavirus.

Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1.

Enfuvirtide (T - 20): a novel human immunodeficiency virus type 1 fusion inhibitor.

A Soluble Factor (s) Secreted from CD8 + T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV - 1) and prevent the virus from invading human cells.

The paucity of virus - laden CD4 + cells in individuals infected with human immunodeficiency virus type - 1 (HIV - 1) contrasts with the greatly reduced numbers and function of these lymphocytes.

Dr. Deborah Anderson from Boston University School of Medicine (BUSM) and her colleagues are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV - 1).

Human immunodeficiency virus type 1 (HIV - 1) is a virus that is spread through unprotected sexual activity, infected drug needles, during pregnancy from mother to child, and through infected breast milk.

Proteolytically produced carboxyl - terminal fragments of the human immunodeficiency virus type - 1 (HIV - 1) Tat protein that include a conserved region rich in arginine and lysine bind specifically to transactivation response RNA sequences (TAR).

Human immunodeficiency virus type 1 (HIV - 1), the cause of human acquired immunodeficiency syndrome (AIDS), is a zoonotic infection of staggering proportions and social impact.

Dendritic cells exposed to human immunodeficiency virus type - 1 transmit a vigorous cytopathic infection to CD4 + T cells

The novel CXCR4 antagonist KRH - 3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.

Specific interactions between the viral coreceptor CXCR4 and the biguanide - based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.

Mutations in the N - terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis

The human immunodeficiency virus type 1 (HIV - 1) is an enveloped retrovirus that undergoes assembly at specific sites in infected cells.